H pylori infection vaccine therapy (Recalcine/Pontifical Catholic University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameH pylori infection vaccine therapy (Recalcine/Pontifical Catholic University)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHelicobacter pylori infection

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryChile

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesRecalcine Pharmaceutical Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRecalcine Pharmaceutical Corp Pontificia Universidad Catolica De Chile

Active IndicationsN/A

Inactive IndicationsHelicobacter pylori infection

Other Information

ATC CodeN/A